Press Release: F&S Best Practice Awards 2018

Frost & Sullivan Awards PMD Solutions with Visionary Innovation Leadership Award in London

DATE: 5th October 2018

Frost & Sullivan awards PMD Solutions with the 2018 Visionary Innovation Leadership award for the non-invasive respiratory market at the Best Practices banquet in London. Best practice companies lead the way and set the example for others. The Best Practices Awards have identified exemplary achievements within a multitude of industries and functional disciplines for the last 18 years. Frost & Sullivan conducts best practices research to properly identify unrivalled innovation and leadership among companies, products, processes and executives.

This award recognises how this leadership position enables a market participant to deliver highly competitive products and solutions that transform the way individuals and business perform daily activities. At the heart of visionary innovation is a deep understanding of the implications and global ramifications of industry Mega Trends.

“With an aggressive strategy for reaching a market leadership position by 2020, and investing over 8 years in designing its industry-leading clinical research programme, PMD is committed to continuing this evidence-based approach to expand its application and geographical reach. In addition, PMD’s growing clinical support and acceptance makes them an exciting company to watch in the European non-invasive respiratory market” says Dorman Followwill, Senior Partner, Transformational Health at Frost & Sullivan.

RespiraSense™, the world’s only continuous and motion-tolerant respiratory rate monitor, is a revolution in early detection of patient deterioration,” says Myles Murray, PMD Solutions CEO. “PMD is honoured to receive this prestigious recognition. This award comes at a time where 8 years of clinical evidence and market acceptance by NHS England and other global leaders in patient monitoring positions PMD for rapid growth. Thereby, contributing to fulfilling PMD’s vision of improving patient outcomes by making every breath count.”

“PMD Solutions’ RespiraSense™ is properly aligned with the future of Frost & Sullivan-identified Mega Trends by reducing the need for healthcare resources, enabling RR data to be transmitted to providers, and sending alerts through wireless sensor platforms.” Brahadeesh C, Industry Analyst, Transformational Health at Frost & Sullivan.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community.

Contact: Start the discussion

About PMD Solutions
PMD Solutions is the leader in non-invasive respiratory rate monitoring solutions. PMD is focused on developing innovative and patient-friendly technologies to support healthcare provider’s early prevention model of patient care. Established in 2011 on a fundamental clinical need to measure patients breathing rates, which is amiss, is a significant indicator of deterioration, the company develops groundbreaking medical devices for the monitoring and diagnosis of respiratory conditions with the fundamental belief of making every breath count.  With several clinical applications, the primary focus of the technology addresses the global technological deficit of accurate and continuous respiratory rate monitoring. Core products include class-leading continuous and motion-tolerant respiratory rate monitors and population sleep screening diagnostic devices.

PMD Solutions operates from Cork, Ireland, a region recognised as one of the largest exporters of medical products in Europe and one of the five global emerging medical device hubs.


Join the conversation on Twitter: @PMD_Respiratory and #MakingEveryBreathCount

Contact us:


Recommended Posts